New health care policy changes will soon affect weight-loss drugs [TheStreet.com]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: TheStreet.com
Medications that lower blood sugar levels to promote weight loss have become increasingly popular over the past few years. Typically used for treating diabetes, GLP-1s have become an increasingly mainstream option for weight loss and treating obesity. The skyrocketing demand for popular GLP-1s like Ozempic, Wegovy, and Mounjaro has created product shortages, which is particularly worrisome for patients managing their diabetes. Novo Nordisk NVO and Eli Lilly LLY manufacture the top three weight loss drugs on the market, but heightened demand is promoting innovation within the field and allowing cheaper competitor products to emerge. Don't miss the move: Subscribe to TheStreet's free daily newsletter The GLP-1s are expensive and aren't covered by insurance, forcing consumers to pay for mainstream name brands out of pocket. Contrave is a weight loss drug that is far cheaper and easier for consumers to administer. The GLP1s can cost $1,000 per month and must be administer
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Should You Invest in the VanEck Pharmaceutical ETF (PPH)? [Yahoo! Finance]Yahoo! Finance
- 1 Stubborn Cloud and 2 Silver Linings for Eli Lilly Stock [Yahoo! Finance]Yahoo! Finance
- Woman Dies After Using Weight-Loss Drug In U.K.'s First Case [Forbes]Forbes
- Eli Lilly and Company (LLY): Among the Best Low Volatility Stocks to Invest In Now [Yahoo! Finance]Yahoo! Finance
- PRIMECAP Management's Strategic Moves in Q3 2024: A Closer Look at Eli Lilly's Position Reduction [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 10/30/24 - Miss
LLY
Sec Filings
- 11/8/24 - Form 144
- 11/8/24 - Form 4
- 11/5/24 - Form 4
- LLY's page on the SEC website